Guangdong Jiaying Pharmaceutical Co Ltd (002198) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.065x

Based on the latest financial reports, Guangdong Jiaying Pharmaceutical Co Ltd (002198) has a cash flow conversion efficiency ratio of -0.065x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-45.73 Million ≈ $-6.69 Million USD) by net assets (CN¥709.01 Million ≈ $103.75 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See debt-free asset ratio of Guangdong Jiaying Pharmaceutical Co Ltd to measure how much of total assets are equity-financed.

Guangdong Jiaying Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2004–2025)

This chart illustrates how Guangdong Jiaying Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check 002198 operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.

Guangdong Jiaying Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Guangdong Jiaying Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
EMS Limited NSE:EMSLIMITED	-0.029x
P.C.B Tec TA:PCBT	0.032x
Skel fjárfestingafélag hf. IC:SKEL	-0.001x
Bioteque TWO:4107	0.057x
Nanning Baling Technology SHE:002592	-0.008x
Falcon Oil & Gas Ltd. V:FO	-0.027x
JNK India Ltd NSE:JNKINDIA	0.018x
Iljin HySolus Co Ltd KO:271940	0.008x

Annual Cash Flow Conversion Efficiency for Guangdong Jiaying Pharmaceutical Co Ltd (2004–2025)

The table below shows the annual cash flow conversion efficiency of Guangdong Jiaying Pharmaceutical Co Ltd from 2004 to 2025. For the full company profile with market capitalisation and key ratios, see market value of Guangdong Jiaying Pharmaceutical Co Ltd.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥717.93 Million ≈ $105.06 Million	CN¥9.00 Million ≈ $1.32 Million	0.013x	-84.38%
2024-12-31	CN¥758.22 Million ≈ $110.95 Million	CN¥60.85 Million ≈ $8.90 Million	0.080x	-37.81%
2023-12-31	CN¥762.98 Million ≈ $111.65 Million	CN¥98.45 Million ≈ $14.41 Million	0.129x	+246.14%
2022-12-31	CN¥728.42 Million ≈ $106.59 Million	CN¥27.15 Million ≈ $3.97 Million	0.037x	-50.74%
2021-12-31	CN¥684.48 Million ≈ $100.16 Million	CN¥51.80 Million ≈ $7.58 Million	0.076x	-46.64%
2020-12-31	CN¥683.01 Million ≈ $99.95 Million	CN¥96.87 Million ≈ $14.18 Million	0.142x	+625.55%
2019-12-31	CN¥663.17 Million ≈ $97.04 Million	CN¥12.96 Million ≈ $1.90 Million	0.020x	-75.28%
2018-12-31	CN¥785.35 Million ≈ $114.92 Million	CN¥62.10 Million ≈ $9.09 Million	0.079x	+93.56%
2017-12-31	CN¥749.81 Million ≈ $109.72 Million	CN¥30.63 Million ≈ $4.48 Million	0.041x	-24.27%
2016-12-31	CN¥984.87 Million ≈ $144.12 Million	CN¥53.13 Million ≈ $7.77 Million	0.054x	+18.52%
2015-12-31	CN¥929.70 Million ≈ $136.04 Million	CN¥42.31 Million ≈ $6.19 Million	0.046x	-61.99%
2014-12-31	CN¥863.35 Million ≈ $126.33 Million	CN¥103.36 Million ≈ $15.13 Million	0.120x	+398.08%
2013-12-31	CN¥809.66 Million ≈ $118.48 Million	CN¥19.46 Million ≈ $2.85 Million	0.024x	+26.80%
2012-12-31	CN¥278.08 Million ≈ $40.69 Million	CN¥5.27 Million ≈ $771.40K	0.019x	+555.86%
2011-12-31	CN¥270.51 Million ≈ $39.58 Million	CN¥781.89K ≈ $114.42K	0.003x	-96.21%
2010-12-31	CN¥258.47 Million ≈ $37.82 Million	CN¥19.70 Million ≈ $2.88 Million	0.076x	-34.25%
2009-12-31	CN¥241.42 Million ≈ $35.33 Million	CN¥27.98 Million ≈ $4.09 Million	0.116x	+144.87%
2008-12-31	CN¥226.35 Million ≈ $33.12 Million	CN¥10.71 Million ≈ $1.57 Million	0.047x	-45.15%
2007-12-31	CN¥212.62 Million ≈ $31.11 Million	CN¥18.35 Million ≈ $2.68 Million	0.086x	-72.96%
2006-12-31	CN¥82.63 Million ≈ $12.09 Million	CN¥26.37 Million ≈ $3.86 Million	0.319x	+16.54%
2005-12-31	CN¥64.39 Million ≈ $9.42 Million	CN¥17.63 Million ≈ $2.58 Million	0.274x	+52.64%
2004-12-31	CN¥48.97 Million ≈ $7.17 Million	CN¥8.78 Million ≈ $1.29 Million	0.179x	--

About Guangdong Jiaying Pharmaceutical Co Ltd

SHE:002198 China Drug Manufacturers - General

Market Cap

$248.79 Million

CN¥1.70 Billion CNY

Market Cap Rank

#15636 Global

#4571 in China

Share Price

CN¥3.35

Change (1 day)

+2.13%

52-Week Range

CN¥2.96 - CN¥8.43

All Time High

CN¥14.97